Volume 17, Number 12—December 2011
Research
Hepatitis E Virus in Rats, Los Angeles, California, USA
Table 3
Sample type and source | log10 ID50 | log10 RT-PCR50 |
---|---|---|
Feces | ||
Rat B76† | <1 | 3.4 |
Rat B84† |
<1 |
3.4 |
Intestinal contents: Rat B182 | ||
Small intestine | <3 | 4.9 |
Cecum | <3 | 5.4 |
Colon |
<3 |
4.9 |
Serum | ||
Rat B182 | ND | 3.7 |
Rat B300 | ND | <2.2 |
Rat B350 |
3.7 |
4.7 |
Liver | ||
Rat B182 | 4.7 | 7.2 |
Rat B300 | 4.2 | 5.7 |
Rat B350 | 6.2 | 7.7 |
*Values are per milliliter or per gram. HEV, hepatitis E virus; ID50, 50% infectious dose; RT-PCR50, 50% reverse transcription PCR titer; ND, not determined.
†Serum from wild rats was injected into laboratory rats B76 and B84. Samples from these 2 rats were serially passaged into other laboratory rats (wild rat → rat B76 → rat B300; wild rat → rat B84 → rat B182 → rat B350).
1Current affiliation: Embassy of France, Beijing, People’s Republic of China.
2Current affiliation: National Institutes of Health, Frederick, Maryland, USA.
Page created: November 30, 2011
Page updated: November 30, 2011
Page reviewed: November 30, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.